Origin and Mechanism of Action
All heparinoid drugs are of biological origin. The main source for their industrial production is the mucosa of the porcine intestine, from which the necessary sulfated glycosaminoglycans are extracted.
The mechanism of action of heparinoids is fundamentally similar to that of standard heparin. They do not possess direct anticoagulant activity of their own, but act as potent catalysts. Heparinoids bind to antithrombin III (a natural inhibitor of blood coagulation) and significantly enhance its ability to suppress active factors of the coagulation cascade.
Despite this similarity, heparinoids are classified into a separate group. This is because their pharmacological characteristics, the ratio of inhibitory activity against various coagulation factors, and their effect on blood cellular elements differ significantly from both unfractionated and low-molecular-weight heparins.
Sulodexide: composition and pleiotropic effects
One of the main representatives of the group is sulodexide. It is a combined drug that represents a natural mixture of two glycosaminoglycans. The bulk of its composition is formed by heparan sulfate, and about 20% is dermatan sulfate.
From a pharmacodynamic perspective, sulodexide exhibits pronounced selectivity. It predominantly reduces the activity of factor Xa, whereas its inhibitory effect on thrombin (factor IIa) remains very weak.
A crucial feature of sulodexide is the presence of additional (pleiotropic) effects that significantly expand the scope of its clinical application:
- Angioprotective effect: the drug effectively protects the vascular endothelium from damage.
- Increase in fibrinolytic activity: promotes the dissolution of formed fibrin strands.
- Hypolipidemic effect: has a positive effect on lipid metabolism.
Due to this comprehensive action, sulodexide is indicated for peripheral vascular diseases associated with a high risk of thrombosis. It is also used for the prevention of pulmonary embolism (against the background of deep vein thrombosis) and as part of secondary prevention of myocardial infarction.
Unlike many other anticoagulants, sulodexide is available not only in parenteral forms (for intravenous and intramuscular administration), but also in oral dosage forms. The main side effect requiring medical supervision remains the risk of hemorrhagic complications.
Danaparoid sodium and solving the problem of thrombocytopenia
The second key representative of the group is danaparoid sodium. Its composition is more complex and includes a mixture of three components: heparan sulfate, dermatan sulfate, and chondroitin sulfate.
The pharmacodynamic profile of danaparoid sodium is also characterized by the fact that the inhibition of factor Xa is significantly more pronounced than the suppression of prothrombin activity. The drug is intended for subcutaneous administration and is widely used for both the prevention and treatment of venous thrombosis.
The key advantage of danaparoid sodium, which radically distinguishes it from classical heparins, lies in its interaction with blood cells. This drug does not bind to platelet factor 4. As a consequence, it does not trigger a pathological immune response and does not cause severe complications such as thrombocytopenia.
This very property determines its main clinical indication: danaparoid sodium is the absolute drug of choice in cases where previous therapy with standard heparin is complicated by a drop in platelet count.
Briefly: answers to topical questions
What are the contraindications to the use of sulodexide?
Contraindications to the use of sulodexide include:
- hypersensitivity to sulodexide or heparin-like substances;
- hemorrhagic diathesis;
- diseases with increased bleeding tendencies;
- first trimester of pregnancy;
- breastfeeding period;
- acute hemorrhagic states.
To avoid confusing the composition of the drugs, remember the addition rule: Sulodexide is two sulfates (heparan + dermatan). Danaparoid is those same two plus a third (chondroitin sulfate).
Class and exam questions
What is the main clinical advantage of danaparoid sodium over conventional heparin?
Danaparoid sodium does not bind to platelet factor 4. Due to this, it does not cause thrombocytopenia and serves as the drug of choice when this complication develops during heparin therapy.
Which blood coagulation factor do heparinoids affect the most?
Drugs of this group predominantly reduce factor Xa activity. Their inhibitory effect on thrombin (factor IIa) is significantly weaker.
Do heparinoids exist in tablets or capsules?
Yes, unlike standard heparins, sulodexide has dosage forms not only for parenteral (intravenous, intramuscular) but also for oral administration.
What else to study on this topic
- Biochemical mechanism of interaction of sulfated glycosaminoglycans with antithrombin III.
- Pathogenesis of heparin-induced thrombocytopenia and the role of platelet factor 4.
- Pleiotropic effects of sulodexide: mechanisms of angioprotection and hypolipidemic action.
- Comparative characteristics of factor Xa and factor IIa (thrombin) inhibition.
- Rationale for the use of heparinoids in secondary prevention of myocardial infarction.
Master the entire topic in the «Pharmacology» course
This is a summary. The course covers everything tested in classes and exams.
- Complete study guide on the topic "Heparinoids" and 5,304 other pages of the subject
- Assignments and quizzes after every topic — just like in a colloquium
- AI tutor answers questions on the topic anytime
- 116 video lessons on the subject
Other topics in the section "Drugs affecting hemostasis and thrombosis"
Free video lessons: pharmacologyShort lessons with study notes — no registration required.
Prepared by WhiteCoat Pro faculty in accordance with the medical school curriculum. For educational purposes only.